Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Influenza Congress USA

12 Nov 2012 - 13 Nov 2012 - Washington DC, USA



Bookmark and Share


Innovation and opportunity for pharma, biotech, healthcare and investors 

The 4th annual Influenza Congress USA is where key decision makers from pharma, biotech and government come together to plan their development strategies and share best practice with their peers in ‘flu vaccine manufacturing.

Last year, we had senior executives from GSK, Novartis, Sanofi Pasteur, CSL and over 100 other companies discussing adjuvant approval in the US, universal vaccine development, cell-based vaccine development, biotech partnering and funding, delivery, experimental challenge studies and novel egg-based vaccine manufacturing.

Come to Influenza Congress USA and learn:


· How to grow business in light of current developments – H5N1, adjuvant approval, 

cell-based vaccine commercialization, low volume manufacturing

· How to navigate regulatory compliance

· How to fast track FDA approval

· How to monetize new discoveries sooner

· How to eliminate research and manufacturing bottlenecks

· How to attract investment and funding

· How to choose partners

· How to identify the most cost-effective technologies


Can you afford not to be here?


For more information contact, please visit our website, www.terrapinn.com/influenza, or call +1 212 379 6320.



Further information
Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
The Spice of Life
Scientists discover important genetic source of human diversity.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
The Power of Three
Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!